Intracranial Aneurysm Market Trends

Growth Drivers

• Advancements in medical technology: Advances in embolization coils, such as hydrogel-coated coils, improve occlusion rates and reduce recurrence. For instance, hydrogel-coated coils are fully detachable, with a platinum core wrapped in hydrogel. Coils are available in 0.018- and 0.035-inch systems. These coils can extend to four times their size after 20 minutes of deployment, resulting in a highly effective mechanical vascular blockage.
  
  Modern flow-diverting stents like the Pipeline Embolization Device, redirect blood flow away from aneurysms, promoting natural healing and reducing rupture risk.Improved diagnostic imaging such as high-resolution 3D imaging allows precise mapping of aneurysm size, shape, and location, enabling targeted interventions. AI enhances the detection of aneurysms in medical imaging, reducing diagnostic errors and improving early intervention rates. Additionally, robotic systems allow for greater precision during endovascular procedures, reducing operator fatigue and improving outcomes for complex cases.
• Rising awareness and diagnosis rates: Increased understanding of the condition among patients and healthcare providers, along with advancements in diagnostic technologies, has led to earlier detection and treatment, contributing to intracranial aneurysm market expansion. Non-profit organizations and healthcare providers are increasingly promoting awareness about intracranial aneurysms, their risk factors, and symptoms. For instance, Brain Aneurysm Awareness Month is observed in September, emphasizing the importance of early detection.
  
  Moreover, organizations' campaigns have educated millions globally. According to the World Health Organization, by 2031, all countries will have an active awareness or advocacy campaign for neurological illnesses.
• Government and private investments: Governments in developed and emerging intracranial aneurysm markets are allocating funds for neurological research, including better diagnostic and treatment solutions for intracranial aneurysms. The Morrison Government of Australia is investing USD 21.8 million in critical research that could lead to advances in treating neurological illnesses. Private companies are heavily investing in the development of advanced medical devices, embolization coils, and stents. These innovations aim to improve patient outcomes and reduce complications.
  
  Moreover, the increasing collaboration between public and private sectors is expected to reduce the burden of intracranial aneurysms.

Challenges

• High cost of treatment: Advanced treatments like endovascular coiling, stent placement, and surgical clipping are costly, making them inaccessible to many patients, particularly in low-and middle-income countries. The high price of medical devices such as flow diverters, embolization coils, and imaging systems limits adoption in resource-constrained settings.
• Risk of complications: Procedures for treating intracranial aneurysms, such as coiling or clipping, carry risks of complications, including stroke, vessel rupture, or neurological deficits, which may deter patients and providers. Treated aneurysms can sometimes recur, requiring additional interventions that increase patient burden and healthcare costs.